We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma

News   Feb 12, 2008

 
Xencor Initiates Phase I Clinical Trial with XmAb2513 in Lymphoma
 
 
Advertisement
 

RELATED ARTICLES

Study Investigates Racial Disparities in Clinical Trial Recruitment

News

Scientists are increasingly turning to electronic-based recruitment methods to encourage participation in clinical trials. Little is known about how this use of technology compares to more traditional clinical trial recruitment strategies, and some researchers worry that an overreliance on technology has the potential to exclude an eligible and interested diverse participant population.

READ MORE

How Giant Spider Venom Might Help Sufferers of Irritable Bowel Syndrome

News

Molecules from the venom of one of the world’s largest spiders could help a team of Institute for Molecular Bioscience-led researchers tailor pain blockers for people with irritable bowel syndrome (IBS).

READ MORE

CD19 in Brain Cells May Be Cause of Immunotherapy-Related Neurotoxicity

News

New research has uncovered the presence of CD19 -- a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma -- in brain cells that protect the blood brain barrier (BBB).

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE